Maximino Redondo | Health Professions | Best Scholar Award

Published on by Academic Excellence

Prof. Dr. Maximino Redondo | Health Professions | Best Scholar Award

Prof. Dr. Maximino Redondo, Universidad de Málaga, Spain

Dr. Maximino Redondo Bautista is an accomplished Spanish physician and professor, with an extensive career in clinical laboratory medicine and health research. Since 1993, he has served as a Medical Specialist at Hospital Universitario Costa del Sol in Málaga, while concurrently advancing academia as a full-time professor at the University of Málaga. With six recognized research sexennia and leadership of the hospital’s Research Unit, Dr. Redondo has made significant strides in translational medicine, oncology, and chronic disease studies. He has led 18 competitive research projects supported by the Instituto de Salud Carlos III and regional health bodies. His international collaborations and contributions to multicenter studies have shaped evidence-based healthcare practices in Spain. Through consistent involvement in national research networks like REDISSEC and RICAPPS, he promotes innovation, training, and the implementation of real-world healthcare solutions.

Profile

Google Scholar

🌟 Assessment of Suitability for the Research for Best Scholar Award: Dr. Maximino Redondo Bautista

Summary of Suitability:

Dr. Maximino Redondo Bautista stands as a highly qualified candidate for the Research for Best Scholar Award, bringing decades of academic, clinical, and research excellence to the forefront. With a strong dual appointment as a Medical Specialist at the Hospital Universitario Costa del Sol since 1993 and a Full Professor (Catedrático) at the University of Málaga since 2023, his contributions straddle both advanced medical practice and academic leadership.

Dr. Redondo earned his Doctorate in Medicine and Surgery from the University of Granada in 1991, along with specialized academic training in Epidemiology and Clinical Research. His professional journey reflects a consistent climb, with long-term involvement in academia and research, having held multiple professorial roles and received continuous competitive research funding. Over the years, he has served as Principal Investigator in 18 competitive research projects funded by the Instituto de Salud Carlos III and the Andalusian Health Council.

🎓 Education

Dr. Redondo holds a Doctorate in Medicine and Surgery from the University of Granada (1991), which laid the groundwork for his specialization in clinical analysis and translational medical research. He also earned a University Expert Degree in Epidemiology and Clinical Research from the same university in 2000. His academic journey began with a residency (MIR) in Clinical Analysis at the University Hospital Virgen de las Nieves (1986–1990), followed by key professional training in top Spanish medical centers. Over the years, he has cultivated a strong background in biomedical sciences and public health, supported by further academic certification and participation in national programs. His extensive formal education, complemented by teaching roles since 1992, has empowered him to nurture emerging scientists, shape academic curricula, and contribute to policy-oriented research in health sciences.

💼 Professional Experience

Dr. Maximino Redondo has more than three decades of experience in clinical medicine, research, and higher education. Since 1993, he has worked as a Clinical Laboratory Specialist at Hospital Universitario Costa del Sol. In academia, he has been a professor at the University of Málaga since 1992, most recently serving as Chair Professor in the Department of Surgical Specialties, Biochemistry, and Immunology. He also served as a Tenured Professor and Associate Professor over the years. His extensive career includes significant research leadership: serving on competitive programs at Instituto de Salud Carlos III and the Andalusian Health Council. He coordinates national research networks, leads clinical studies, and contributes to translational research initiatives. Dr. Redondo’s integrated professional approach bridges patient care, scientific inquiry, and academic excellence, shaping policy and fostering innovation in health service delivery.

🏅 Awards and Recognition 

Dr. Redondo has been widely recognized for his exceptional contributions to biomedical research, health policy, and academic mentorship. His work has earned six officially recognized sexenios de investigación (six-year research productivity periods), a distinguished mark in Spanish academia. He has led 18 competitive research projects and was repeatedly selected for national Intensification Programs by both Instituto de Salud Carlos III and the Andalusian Ministry of Health. Dr. Redondo played a central role in the REDISSEC and RICAPPS research networks, coordinating multicenter studies and leading national healthcare strategies. His efforts have translated research findings into impactful healthcare practices and evidence-based policy reforms. As a principal investigator and mentor, he has contributed to researcher training programs and advanced Spain’s health system through innovation and collaborative research. His influence spans medical education, diagnostics, and national public health frameworks.

🌍 Research Skills On Health Professions

Dr. Redondo excels in translational research, clinical epidemiology, biostatistics, and health services evaluation. His primary focus lies in oncology, chronic illness management, and the integration of research findings into real-world clinical practice. His skillset includes designing multicenter studies, applying evidence-based medicine, and leveraging laboratory diagnostics to inform health policies. As a senior researcher and group leader in the RICAPPS (RD21/0016/0015 and RD24/0005/0016) and REDISSEC networks, he coordinates collaborative research among hospitals, universities, and institutes across Spain. He also mentors early-career researchers, promotes interdisciplinary partnerships, and strengthens knowledge translation in healthcare. His ability to secure competitive funding and lead innovative health projects demonstrates scientific and managerial expertise. Dr. Redondo also contributes to editorial, evaluation, and strategic committees, ensuring the long-term sustainability and impact of research initiatives aimed at improving public health outcomes.

📖 Publication Top Notes

  • 🔬 Overexpression of clusterin in human breast carcinoma
    Authors: M. Redondo, E. Villar, J. Torres-Muñoz, T. Tellez, M. Morell, C.K. Petito
    Citation: The American Journal of Pathology, 157(2), 393–399.
    Year: 2000

  • 🧪 Immunotherapy: a challenge of breast cancer treatment
    Authors: M. García-Aranda, M. Redondo
    Citation: Cancers, 11(12), 1822.
    Year: 2019

  • 🧫 Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia
    Authors: C. Marchal, M. Redondo, M. Padilla, J. Caballero, I. Rodrigo, J. Garcia, et al.
    Citation: Histology and Histopathology, 2004.
    Year: 2004

  • 🧠 Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus
    Authors: E. Matas-Rico, B. Garcia-Diaz, P. Llebrez-Zayas, D. López-Barroso, L. Santin, M. Redondo, et al.
    Citation: Molecular and Cellular Neuroscience, 39(3), 342–355.
    Year: 2008

  • 💉 Bcl-2 inhibition to overcome resistance to chemo- and immunotherapy
    Authors: M. García-Aranda, E. Pérez-Ruiz, M. Redondo
    Citation: International Journal of Molecular Sciences, 19(12), 3950.
    Year: 2018

  • 🧬 Presence of HPV 16 sequences in laryngeal carcinomas
    Authors: M. Perez-Ayala, F. Ruiz-Cabello, F. Esteban, A. Concha, M. Redondo, et al.
    Citation: International Journal of Cancer, 46(1), 8–11.
    Year: 1990

  • 🧻 The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs
    Authors: M. Muñoz, R. Coveñas, F. Esteban, M. Redondo
    Citation: Journal of Biosciences, 40, 441–463.
    Year: 2015

  • 🫁 Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters
    Authors: M. Redondo, A. Concha, R. Oldiviela, A. Cueto, A. Gonzalez, F. Garrido, et al.
    Citation: Cancer Research, 51(18), 4948–4954.
    Year: 1991

  • 🔬 NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2
    Authors: M. Muñoz, M. Rosso, F.J. Aguilar, M.A. González-Moles, M. Redondo, et al.
    Citation: Investigational New Drugs, 26, 111–118.
    Year: 2008

  • 🎯 Protein kinase targets in breast cancer
    Authors: M. García-Aranda, M. Redondo
    Citation: International Journal of Molecular Sciences, 18(12), 2543.
    Year: 2017

Wentao Han | Medicine | Best Researcher Award

Published on by Academic Excellence

Dr. Wentao Han | Medicine | Best Researcher Award

Dr. Wentao Han, Department of Ophthalmology, The Second Xiangya Hospital, Central South University, China

Wentao Han is a dedicated ophthalmology researcher specializing in diabetic eye complications, dry eye syndrome, and gene therapy. Currently pursuing his research at the Second Xiangya Hospital of Central South University, China, he has demonstrated a strong passion for advancing medical science through innovative studies. His contributions to ocular disease research, particularly in understanding the gut-eye axis and corneal wound healing, highlight his interdisciplinary approach. He has authored multiple high-impact journal articles and actively collaborates with global scholars. His research on machine learning applications in medical diagnosis showcases his forward-thinking vision in integrating AI with healthcare. Beyond academia, Wentao Han serves as a reviewer for prestigious journals, contributing to the integrity of scientific publications. His dedication to translational medicine and biomarker identification continues to shape new therapeutic strategies. His work aims to bridge laboratory findings with clinical applications, improving patient outcomes in ophthalmology and metabolic diseases.

Professional Profile 

Orcid

Suitability for the Research for Best Researcher Award – Wentao Han

Wentao Han demonstrates a strong research background in ophthalmology, particularly in the areas of diabetic eye complications, dry eye syndrome, and corneal wound healing. Currently pursuing research at the Second Xiangya Hospital of Central South University, he has made notable contributions to the field, with multiple high-impact publications in reputable journals. His expertise in the “gut metabolites–inflammation–eye axis” and gene therapy for Meibomian Gland Dysfunction (MGD) highlights his innovative approach to addressing critical challenges in ophthalmology.

His publication record is impressive, with multiple papers in Q1 and Q2 journals, including Pharmaceutics, The Ocular Surface, Acta Diabetologica, and Journal of Medical Internet Research. Notably, his work on machine learning prediction models, autophagy in retinal precursor cells, and the gut-eye axis showcases a multidisciplinary research approach. His role as an invited reviewer for respected journals further establishes his credibility in the academic community.

🎓 Education 

Wentao Han is currently pursuing advanced medical research at Central South University, Changsha, China, within the Department of Ophthalmology at the Second Xiangya Hospital. His academic journey reflects a deep commitment to ophthalmic research, focusing on diabetic retinopathy, ocular surface disorders, and corneal healing mechanisms. Through rigorous training and hands-on experience in clinical settings, he has honed his expertise in evidence-based medicine and translational research. His coursework and mentorship under leading ophthalmologists have allowed him to integrate molecular biology with patient-centered investigations. Additionally, he actively participates in research seminars, workshops, and scientific collaborations, reinforcing his knowledge of bioinformatics, gene therapy, and regenerative medicine. His strong foundation in medical sciences, combined with a keen interest in technological advancements, positions him as a promising young researcher in ophthalmology. His education has equipped him with critical skills to contribute to groundbreaking discoveries in the field of ocular diseases.

💼 Professional Experience 

As a researcher in ophthalmology at the Second Xiangya Hospital of Central South University, Wentao Han has contributed significantly to understanding diabetic eye complications and ocular disease mechanisms. His professional experience includes conducting clinical and preclinical studies on dry eye syndrome, corneal wound healing, and the gut-eye axis. He has extensive expertise in meta-analyses, molecular diagnostics, and the application of artificial intelligence in disease prediction. His work in identifying novel biomarkers for diabetic retinopathy has been widely recognized. Additionally, he collaborates with interdisciplinary teams, integrating bioinformatics and evidence-based medicine to develop innovative treatment approaches. Han’s active involvement in academic publishing and peer review for high-impact journals reflects his commitment to advancing medical knowledge. His current projects involve investigating gene therapy for meibomian gland dysfunction and corneal regeneration, with the aim of translating scientific discoveries into clinical applications that enhance patient care in ophthalmology.

🏅 Awards and Recognition 

Wentao Han has received multiple recognitions for his outstanding contributions to ophthalmic research. He has been an invited reviewer for prestigious journals such as Cell Death Discovery (IF = 7) and Acta Diabetologia (IF = 3.9), underscoring his expertise in diabetes-related ocular disorders. His research on gut metabolites’ role in eye diseases has been acknowledged at international conferences. Several of his published articles in Q1 journals have earned high citations, reflecting their impact on the scientific community. Han has also contributed to the development of machine learning prediction models for gestational diabetes mellitus, further showcasing his interdisciplinary proficiency. His involvement in groundbreaking studies on corneal wound healing has positioned him as a promising young researcher in ophthalmology. With a strong publication record, peer recognition, and contributions to medical advancements, Han continues to be a driving force in translational ophthalmic research and clinical innovation.

🌍 Research Skills On Medicine

Wentao Han possesses a diverse set of research skills that bridge molecular biology, clinical medicine, and artificial intelligence applications in ophthalmology. His expertise includes conducting systematic reviews, meta-analyses, and experimental research on diabetic retinopathy and dry eye syndrome. He is proficient in bioinformatics tools for gene analysis and biomarker identification, which he applies to precision medicine. Han is skilled in laboratory techniques such as immunohistochemistry, cell culture, and animal models for ocular disease studies. His ability to integrate AI and machine learning into medical research has led to innovative predictive models for disease diagnosis. Additionally, his work in gene therapy for corneal and meibomian gland dysfunction highlights his translational research capabilities. Han’s interdisciplinary approach allows him to explore novel therapeutic targets, making significant contributions to evidence-based medicine. His research aims to improve diagnostic accuracy and therapeutic interventions in ophthalmic and metabolic disorders.

📖 Publication Top Notes

  • Research Progress and Potential Applications of Spermidine in Ocular Diseases
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Journal of Medical Internet Research, 2022-03-16
    • Year: 2022
    • DOI: 10.2196/26634
  • Genome Analysis and Identification of Key Pathway in Visceral Adipose Tissue from Obesity-Related Diabetes
    • Authors: Wentao Han
    • Citation: Proceedings of the 2021 International Conference on Bioinformatics and Intelligent Computing, 2021-01-22
    • Year: 2021
    • DOI: 10.1145/3448748.3448757
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis (Preprint)
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Preprint, 2020-12-19
    • Year: 2020
    • DOI: 10.2196/preprints.26634
  • Construction of a Knowledge Graph for Diabetes Complications from Expert-Reviewed Clinical Evidences
    • Authors: Wentao Han
    • Citation: Computer Assisted Surgery (Abingdon, England), 2020-11-25
    • Year: 2020
    • DOI: 10.1080/24699322.2020.1850866
    • PMID: 33275462
  • Association Between Retinol Binding Protein 4 and Diabetic Retinopathy Among Type 2 Diabetic Patients: A Meta-analysis
    • Authors: Wentao Han, Huagen Wei, Weizheng Kong, Jing Wang, Luqian Yang, Huiqun Wu
    • Citation: Acta Diabetologica, 2020-10
    • Year: 2020
    • DOI: 10.1007/s00592-020-01535-3

 

Mr. Ali Umar | Pharmaceutical | Academic Excellence Award

Published on by Academic Excellence

Mr. Ali Umar | Pharmaceutical | Academic Excellence Award

Mr. Ali Umar, University of Okara, Pakistan

Aliumar, a Pakistani researcher with a Master of Philosophy in Zoology, specializes in nanoparticles synthesis and their biomedical applications. His academic journey started with a B.Sc. in Botany, Chemistry, and Zoology from the University of the Punjab, followed by an M.Sc. in Zoology from the University of Education, Lahore. He then earned his M.Phil. in Zoology from the University of Okara, focusing on sleep disorders in the educational community of Pakistan. Aliumar’s expertise lies in human and environmental health, and his research extends to general zoology and biomedical advancements. With practical experience in synthesizing and characterizing nanomaterials, he has contributed significantly to environmental and human health studies, particularly in the analysis of heavy metals and disease epidemiology. Aliumar has been a visiting lecturer and actively participates in international conferences, enhancing his professional and academic footprint.

Professional Profile

orcid

Summary of Suitability for the Research for Academic Excellence Award

Aliumar demonstrates an impressive profile that aligns well with the criteria for the Research for Academic Excellence Award. His academic background is robust, with a Master of Philosophy in Zoology and a Master’s degree in Zoology, complemented by a Bachelor’s degree in Botany, Chemistry, and Zoology. His research is diverse, spanning nanomaterials, biomedical applications, and environmental health, showcasing a strong interdisciplinary approach.

🎓 Education 

Aliumar completed his Master of Philosophy in Zoology from the University of Okara (2019-2021), where his thesis focused on the epidemiology of sleep disorders in Pakistan’s educational community. He explored major risk factors and associated diseases impacting the population. Earlier, he pursued an M.Sc. in Zoology at the University of Education, Lahore (2017-2019), researching heavy metal concentrations in the feathers of migratory waterfowl. His undergraduate education includes a B.Sc. in Botany, Chemistry, and Zoology from the University of the Punjab (2015-2017). Before university, Aliumar completed his F.Sc. in Pre-Medical (2013-2015) and Matriculation (2011-2013) at BISE Faisalabad, building a solid foundation in the biological sciences. This comprehensive education has equipped him with expertise in environmental health monitoring, nanomaterials research, and interdisciplinary studies combining zoology and environmental science.

💼 Professional Experience 

Aliumar has gained extensive experience in nanomaterials research and education. From 2021 to 2023, he worked in the Applied Zoology Lab at the University of Okara, where he focused on synthesizing and characterizing nanomaterials for biomedical applications. His research encompassed developing materials with antibacterial and wound-healing properties. Since 2022, Aliumar has served as a Visiting Lecturer in the Department of Zoology at the University of Okara, where he teaches and mentors students. His earlier roles include working as a Biology Teacher at Islamia Model College in Mamunkanjan (2018-2019), where he honed his teaching skills and inspired young students to pursue science. His professional journey reflects his dedication to advancing biomedical and environmental health through innovative research and education.

🏅Awards and Recognition 

Aliumar has been recognized for his contributions to biological sciences and nanotechnology. His research on novel nanostructures and their biomedical applications has earned him invitations to speak at international conferences, such as the International Conference on New Trends in Biological Sciences at the University of Okara in 2022 and 2023. His work on environmental health, particularly on heavy metal pollution in waterfowl, was acknowledged by academic peers and contributed to significant publications. He received specialized training in Cage Culture, organized by the Fisheries Development Board of Pakistan, enhancing his expertise in aquaculture and environmental monitoring. Aliumar’s achievements reflect his commitment to scientific excellence, as he continues to make impactful contributions to human and environmental health through interdisciplinary research and innovation.

🌍  Research Skills 

Aliumar possesses a diverse set of research skills in environmental and biomedical sciences. He is proficient in computational pharmacokinetics and molecular docking analysis, which he applies to investigate the interactions of nanomaterials with biological systems. His expertise extends to Density Functional Theory (DFT) analysis for understanding material properties. He is experienced in synthesizing nanomaterials and exploring their biomedical applications, such as wound healing and antimicrobial efficacy. Aliumar also conducts environmental health studies using techniques like Atomic Absorption Spectroscopy (AAS) for pollutant quantification and hematology analysis for Complete Blood Count (CBC) tests. His skills in histopathological techniques, including microtomy and staining, enable him to examine tissue samples under microscopes. Fieldwork for environmental monitoring and the study of disease epidemiology are integral to his research portfolio, emphasizing his multidisciplinary approach.

📖 Publication Top Notes

  • Biocompatibility, antimicrobial efficacy, and therapeutic potential of cobalt carbonate nanoparticles in wound healing, sex hormones, and metabolic regulation in diabetic albino mice
  • Therapeutic Potential of Novel Silver Carbonate Nanostructures in Wound Healing and Antibacterial Activity Against Pseudomonas chengduensis and Staphylococcus aureus
  • Dose-Dependent Effects of Cobalt Nanoparticles on Antioxidant Systems, Hematological Parameters, and Organ Morphology in Albino Mice
  • Research Progress on Migratory Water Birds: Indicators of Heavy Metal Pollution in Inland Wetland Resources of Punjab, Pakistan
  • Metal Nanoparticles: Synthesis Approach, Types and Applications – A Mini Review